Stay in the know
We’ll send you the latest insights and briefings tailored to your needs
Subscribe now
Kramer Levin represented the initial purchaser and the co-manager in connection with a $197.5 million securitization of life sciences and technology loans. The transaction closed on Oct. 23, 2020.
Managing Partner, Finance and Restructuring, US and Head of Securitization, US, New York
Partner, Head of Tax, US, New York
Partner, Head of Executive Compensation and Employee Benefits, US, New York
Special Counsel, New York
We’ll send you the latest insights and briefings tailored to your needs